Arcellx IncNASDAQ:ACLX
- LAST PRICE54.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots53.4400/ 1
- Ask / Lots54.9500/ 3
- Open / Previous Close53.6700 / 54.0000
- Day Range
- 52 Week Range
- Volume414,669
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACLX |
|---|---|---|
| 09:32 ET | 1361 | 53.67 |
| 09:34 ET | 100 | 53.805 |
| 09:38 ET | 438 | 53.96 |
| 09:39 ET | 300 | 53.85 |
| 09:41 ET | 700 | 53.86 |
| 09:43 ET | 848 | 53.99 |
| 09:45 ET | 200 | 54.2 |
| 09:48 ET | 1899 | 54.32 |
| 09:50 ET | 300 | 54.255 |
| 09:52 ET | 1100 | 54.19 |
| 09:54 ET | 200 | 54.2 |
| 09:56 ET | 200 | 54.075 |
| 09:57 ET | 1427 | 53.815 |
| 09:59 ET | 306 | 53.88 |
| 10:01 ET | 1100 | 53.84 |
| 10:03 ET | 100 | 53.855 |
| 10:06 ET | 1338 | 53.99 |
| 10:08 ET | 700 | 53.785 |
| 10:10 ET | 500 | 53.875 |
| 10:12 ET | 700 | 53.89 |
| 10:14 ET | 500 | 53.895 |
| 10:15 ET | 800 | 53.835 |
| 10:17 ET | 600 | 53.93 |
| 10:19 ET | 600 | 54.05 |
| 10:24 ET | 100 | 53.925 |
| 10:26 ET | 100 | 53.93 |
| 10:28 ET | 200 | 53.935 |
| 10:30 ET | 2836 | 53.535 |
| 10:32 ET | 568 | 53.78 |
| 10:33 ET | 344 | 53.88 |
| 10:35 ET | 364 | 53.95 |
| 10:37 ET | 100 | 53.92 |
| 10:39 ET | 100 | 54.2 |
| 10:42 ET | 200 | 54.095 |
| 10:44 ET | 800 | 53.935 |
| 10:50 ET | 100 | 53.945 |
| 10:51 ET | 600 | 54.085 |
| 10:53 ET | 400 | 53.92 |
| 10:57 ET | 400 | 53.885 |
| 11:00 ET | 1100 | 53.9325 |
| 11:04 ET | 200 | 53.925 |
| 11:06 ET | 100 | 53.83 |
| 11:08 ET | 300 | 53.87 |
| 11:09 ET | 500 | 53.93 |
| 11:11 ET | 1033 | 53.84 |
| 11:13 ET | 400 | 53.93 |
| 11:15 ET | 600 | 53.97 |
| 11:18 ET | 400 | 54.075 |
| 11:29 ET | 400 | 54.035 |
| 11:33 ET | 100 | 54.035 |
| 11:36 ET | 600 | 53.935 |
| 11:40 ET | 200 | 54.03 |
| 11:44 ET | 200 | 53.96 |
| 11:45 ET | 200 | 53.93 |
| 11:47 ET | 200 | 53.95 |
| 11:49 ET | 420 | 53.89 |
| 11:54 ET | 100 | 53.875 |
| 11:58 ET | 500 | 54.01 |
| 12:03 ET | 200 | 54.21 |
| 12:14 ET | 100 | 54.265 |
| 12:16 ET | 100 | 54.285 |
| 12:18 ET | 500 | 54.21 |
| 12:36 ET | 100 | 54.1 |
| 12:39 ET | 600 | 54.17 |
| 12:41 ET | 300 | 54.11 |
| 12:43 ET | 496 | 54.27 |
| 12:45 ET | 200 | 54.27 |
| 12:50 ET | 400 | 54.22 |
| 12:54 ET | 100 | 54.185 |
| 12:57 ET | 300 | 54.08 |
| 01:03 ET | 400 | 54.13 |
| 01:12 ET | 300 | 54.28 |
| 01:21 ET | 200 | 54.295 |
| 01:24 ET | 100 | 54.21 |
| 01:35 ET | 200 | 54.13 |
| 01:37 ET | 1100 | 54.19 |
| 01:44 ET | 100 | 54.28 |
| 01:53 ET | 300 | 54.42 |
| 01:57 ET | 600 | 54.275 |
| 02:04 ET | 300 | 54.34 |
| 02:08 ET | 600 | 54.3 |
| 02:09 ET | 100 | 54.32 |
| 02:11 ET | 100 | 54.35 |
| 02:13 ET | 300 | 54.37 |
| 02:15 ET | 500 | 54.4 |
| 02:20 ET | 100 | 54.5 |
| 02:24 ET | 700 | 54.51 |
| 02:26 ET | 100 | 54.47 |
| 02:29 ET | 100 | 54.49 |
| 02:33 ET | 100 | 54.47 |
| 02:36 ET | 100 | 54.465 |
| 02:38 ET | 400 | 54.46 |
| 02:42 ET | 100 | 54.32 |
| 02:44 ET | 200 | 54.37 |
| 02:47 ET | 111 | 54.29 |
| 02:51 ET | 200 | 54.265 |
| 02:54 ET | 24533 | 53.6 |
| 02:56 ET | 12327 | 53.92 |
| 02:58 ET | 7702 | 54.15 |
| 03:00 ET | 1100 | 54.198 |
| 03:02 ET | 751 | 54.16 |
| 03:03 ET | 3562 | 54.24 |
| 03:05 ET | 200 | 54.235 |
| 03:07 ET | 502 | 54.235 |
| 03:09 ET | 351 | 54.23 |
| 03:12 ET | 2490 | 54.2 |
| 03:14 ET | 1080 | 54.07 |
| 03:16 ET | 578 | 54.096 |
| 03:18 ET | 3933 | 54.3 |
| 03:20 ET | 1479 | 54.37 |
| 03:21 ET | 1690 | 54.43 |
| 03:23 ET | 900 | 54.4 |
| 03:25 ET | 1224 | 54.43 |
| 03:27 ET | 981 | 54.27 |
| 03:32 ET | 100 | 54.14 |
| 03:34 ET | 350 | 54.11 |
| 03:36 ET | 520 | 54.18 |
| 03:38 ET | 2503 | 54.23 |
| 03:39 ET | 400 | 54.25 |
| 03:41 ET | 1433 | 54.12 |
| 03:43 ET | 4063 | 54.06 |
| 03:45 ET | 1137 | 54.095 |
| 03:48 ET | 1144 | 54.09 |
| 03:50 ET | 11065 | 54.07 |
| 03:52 ET | 2206 | 54.115 |
| 03:54 ET | 800 | 54.16 |
| 03:56 ET | 3071 | 54.04 |
| 03:57 ET | 6814 | 54.03 |
| 03:59 ET | 12521 | 54 |
May 31, 2024
DJ Arcellx Initiated at Overweight by Piper Sandler, from 6:00AM ET on Friday May 31, 2024 by Dow Jones
6:00AM ET on Friday May 31, 2024 by Dow Jones
May 15, 2024
DJ Arcellx Is Maintained at Buy by Stifel, from 6:58AM ET on Wednesday May 15, 2024 by Dow Jones
6:58AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Arcellx Initiated at Outperform by Evercore ISI Group, from 5:29AM ET on Tuesday May 14, 2024 by Dow Jones
5:29AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
DJ Arcellx Is Maintained at Buy by HC Wainwright & Co., from 1:50PM ET on Monday May 13, 2024 by Dow Jones
1:50PM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcellx Inc | 2.7B | -52.0x | --- |
Rhythm Pharmaceuticals Inc | 2.4B | -8.7x | --- |
Agios Pharmaceuticals Inc | 2.7B | -7.5x | --- |
Geron Corp | 2.7B | -14.7x | --- |
IDEAYA Biosciences Inc | 2.9B | -18.8x | --- |
MoonLake Immunotherapeutics | 2.7B | -57.9x | --- |
Company Information
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Contact Information
- Headquarters
- 800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 240-327-0603
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rami Elghandour
- Chief Financial Officer
- Michelle Gilson
- Chief Medical Officer
- Christopher Heery
- Independent Director
- Ali Behbahani
- Independent Director
- Jill Carroll
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -52.0x |
Price/Sales (TTM) | 22.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
